Leon v. Rite Aid Corp.

774 A.2d 674, 340 N.J. Super. 462
CourtNew Jersey Superior Court Appellate Division
DecidedMay 30, 2001
StatusPublished
Cited by53 cases

This text of 774 A.2d 674 (Leon v. Rite Aid Corp.) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Leon v. Rite Aid Corp., 774 A.2d 674, 340 N.J. Super. 462 (N.J. Ct. App. 2001).

Opinion

774 A.2d 674 (2001)
340 N.J. Super. 462

Maritza LEON, on behalf of herself and all others similarly situated, Plaintiff-Appellant,
v.
RITE AID CORPORATION, and Rite Aid of New Jersey, Inc., Defendants-Respondents.

Superior Court of New Jersey, Appellate Division.

Argued May 8, 2001.
Decided May 30, 2001.

*675 Bruce Greenberg, Newark, argued the cause for appellant (Lite DePalma Greenberg & Rivas, Seeger Weiss, and The Cuneo Law Group, attorneys; Allyn Z. Lite, Newark, on the brief).

Robert A. White, Princeton, argued the cause for respondent (Morgan, Lewis & Bockius, attorneys; Mr. White, on the brief).

Before Judges KESTIN, CIANCIA and ALLEY.

*676 The opinion of the court was delivered by CIANCIA, J.A.D.

Plaintiff Maritza Leon's consumer fraud complaint was dismissed with prejudice for failure to state a claim upon which relief could be granted. R. 4:6-2(e).[1] She appeals and we reverse.

As detailed subsequently, plaintiff's complaint alleged that defendants Rite Aid Corporation and Rite Aid of New Jersey, Inc. (collectively Rite Aid), violated the New Jersey Consumer Fraud Act. Rite Aid advertised that its merchandise, including prescription drugs, was sold at the lowest and best prices when, in fact, different prices were charged to different customers for the same prescription drugs and Rite Aid's own list prices were increased for certain kinds of transactions.

Initially, we emphasize the indulgent standard under which a plaintiff's complaint is evaluated when it is contended that a cause of action has not been stated:

We approach our review of the judgment below mindful of the test for determining the adequacy of a pleading: whether a cause of action is `suggested' by the facts. Velantzas v. Colgate-Palmolive Co., 109 N.J. 189, 192 [536 A.2d 237] (1988). In reviewing a complaint dismissed under Rule 4:6-2(e) our inquiry is limited to examining the legal sufficiency of the facts alleged on the face of the complaint. Rieder v. Department of Transp., 221 N.J.Super. 547, 552 [535 A.2d 512] (App.Div.1987). However, a reviewing court `searches the complaint in depth and with liberality to ascertain whether the fundament of a cause of action may be gleaned even from an obscure statement of claim, opportunity being given to amend if necessary.' Di Cristofaro v. Laurel Grove Memorial Park, 43 N.J.Super. 244, 252 [128 A.2d 281] (App.Div.1957). At this preliminary stage of the litigation the Court is not concerned with the ability of plaintiffs to prove the allegation contained in the complaint. Somers Constr. Co. v. Board of Educ., 198 F.Supp. 732, 734 (D.N.J.1961). For purposes of analysis plaintiffs are entitled to every reasonable inference of fact. Independent Dairy Workers Union v. Milk Drivers Local 680, 23 N.J. 85, 89 [127 A.2d 869] (1956). The examination of a complaint's allegations of fact required by the aforestated principles should be one that is at once painstaking and undertaken with a generous and hospitable approach.
[Printing Mart-Morristown v. Sharp Electronics Corp., 116 N.J. 739, 746, 563 A.2d 31 (1989).]

The continuing viability of these precepts is not open to question. F.G. v. MacDonell, 150 N.J. 550, 556, 696 A.2d 697 (1997).

Plaintiff's complaint, read generously, sets forth the following facts, among others. Rite Aid prominently advertised that it had "the lowest and best prices" on pharmaceuticals. It also actively promoted a best-price guarantee, whereby it would "meet or beat" competitors' prescription prices. Rite Aid pharmacists were encouraged to, and did, charge more than Rite Aid's stated retail price to uninsured customers and other pharmacy customers who were unlikely to challenge its prices. Rite Aid directed its pharmacists to overcharge uninsured pharmacy customers, as well as those who were purchasing "emergency-type" drugs, or drugs designed to remedy an acute condition. *677 These overcharges, referred to as positive overrides, increased prescription prices over Rite Aid's stated retail price from fifty cents to as much as fifteen dollars per prescription. Rite Aid directed and required its pharmacists to raise prescription prices above the Rite Aid retail price on every emergency room prescription, on the first refill of any antibiotic prescription and on certain controlled substances, such as pain killers. In addition, plaintiff asserted that Rite Aid pharmacists were directed to "round up" the stated retail price to the next figure ending in .89 on every prescription—for example, if a prescription's stated retail price was $7.09, Rite Aid pharmacists were required to raise the price to $7.89. If a pharmacy customer asked a prescription price before the prescription was filled, the pharmacist would quote the normal retail price as stated in the company's computer system. When Rite Aid was caught failing to comply with its lowest price program, Rite Aid managers described the "error" as an oversight, and advised concerned customers that the computer system would be updated to reflect the lower price. As part of the alleged "scheme," Rite Aid intentionally sought to, and did, deceive its pharmacy customers into believing that they would be provided Rite Aid's best available price when, in fact, they were charged prices well in excess of Rite Aid's stated retail price.

We believe it clear that these allegations constitute a cause of action under the Consumer Fraud Act, N.J.S.A. 56:8-1 to -20. The goal of the Act is to "protect the consumer against imposition and loss as a result of fraud and fraudulent practices by persons engaged in the sale of goods and services." Fenwick v. Kay American Jeep, Inc., 136 N.J.Super. 114, 117, 344 A.2d 785 (App.Div.1975), rev'd on other grounds, 72 N.J. 372, 371 A.2d 13 (1977); Marascio v. Campanella, 298 N.J.Super. 491, 500, 689 A.2d 852 (App. Div.1997). It has been said that the "history of the Act is one of constant expansion of consumer protection." Gennari v. Weichert Co. Realtors, 148 N.J. 582, 604, 691 A.2d 350 (1997). When the alleged violation is an affirmative act, plaintiff need not prove defendant's intent nor even necessarily actual deceit or fraud. Cox v. Sears Roebuck & Co., 138 N.J. 2, 17-18, 647 A.2d 454 (1994); Skeer v. EMK Motors, Inc., 187 N.J.Super. 465, 470, 455 A.2d 508 (App.Div.1982). Any unconscionable commercial practice is prohibited. Ibid. It has consistently been emphasized that the Act is remedial legislation and should be liberally construed in favor of the consumer. Lettenmaier v. Lube Connection, Inc., 162 N.J. 134, 139, 741 A.2d 591 (1999); Gennari, supra, 148 N.J. at 604, 691 A.2d 350; Cox, supra, 138 N.J. at 15 16, 647 A.2d 454; Barry v. Arrow Pontiac, Inc., 100 N.J. 57, 69, 494 A.2d 804 (1985). A plaintiff need not even show reliance on the violation of the Act as long as an ascertainable loss resulting from defendant's conduct is demonstrated. Carroll v. Cellco Partnership, 313 N.J.Super. 488, 502, 713 A.2d 509 (App.Div.1998).

Some types of false advertising, although not all, are expressly prohibited by the regulations implementing the Act. See e.g., N.J.A.C. 13:45A-9.1 to -9.8 and specifically, N.J.A.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paul Savas v. New Jersey American Water Company, Inc.
New Jersey Superior Court App Division, 2025
Todd Eaddy v. Federal Realty Op Lp
New Jersey Superior Court App Division, 2025
Larry Nikola v. Altice USA, Inc.
New Jersey Superior Court App Division, 2025
Michael Rose v. Borough of Oakland
New Jersey Superior Court App Division, 2025
Wael Nabelsi v. Holmdel Township
New Jersey Superior Court App Division, 2025
Margaret Kleinman, Esq. v. Hackensack University Medical Center
New Jersey Superior Court App Division, 2024
Feivel Phil Gottlieb, Etc. v. Mary C. Beckerle
New Jersey Superior Court App Division, 2024
1401 Ocean LLC v. Zurich American Insurance Company
New Jersey Superior Court App Division, 2024
Lawrence J. Mills v. Golden Nugget Online Gaming, Inc.
New Jersey Superior Court App Division, 2023
Brandon Meredith Hardy v. Susan D. Jackson
New Jersey Superior Court App Division, 2023

Cite This Page — Counsel Stack

Bluebook (online)
774 A.2d 674, 340 N.J. Super. 462, Counsel Stack Legal Research, https://law.counselstack.com/opinion/leon-v-rite-aid-corp-njsuperctappdiv-2001.